Conformis Inc.

NASDAQ:CFMS   3:51:00 PM EDT
0.64
+0.02 (+3.58%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)45.59M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$18.23 Million
Adjusted EPS-$0.09
See more estimates
10-Day MA$0.64
50-Day MA$0.73
200-Day MA$0.78
See more pivots

ConforMIS Inc Stock, NASDAQ:CFMS

600 TECHNOLOGY DRIVE, BILLERICA, MA 01821
United States of America
Phone: (781) 345-9001
Number of Employees: 262

Description

ConforMIS, Inc., a medical technology company, develops, manufactures, and sells customized joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee, as well as provides iJigs, customized single-use patient-specific instruments. It is also developing iTotal Hip, a customized total hip replacement implant. The company markets and sells its products through direct sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, and Hong Kong. ConforMIS, Inc. was founded in 2004 and is headquartered in Bedford, Massachusetts.